Patents by Inventor Robert L. Raison

Robert L. Raison has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120114555
    Abstract: The present invention relates to the treatment of B-cell mediated immune disorders such as rheumatoid arthritis, systemic lupus erythromatomus, diabetes mellitus, and multiple sclerosis. In particular, the present invention relates to the treatment of B-cell mediated immune disorders using antibodies which bind to membrane-bound free light chain expressed on the surface of plasma cell precursors.
    Type: Application
    Filed: April 7, 2010
    Publication date: May 10, 2012
    Applicant: IMMUNE SYSTEM THERAPEUTICS LTD
    Inventors: Andrew T. Hutchinson, Darren R. Jones, Robert L. Raison, Parisa Asvadi, Rosanne D. Dunn
  • Publication number: 20080102027
    Abstract: The present invention relates to the diagnosis and treatment of B-cell disorders such as multiple myeloma (MM). In particular, the present invention relates to the treatment of B-cell disorders using ligands which bind to free lambda light chains expressed on the surface of lymphoid cancer cells.
    Type: Application
    Filed: February 28, 2005
    Publication date: May 1, 2008
    Applicant: PACMAB LIMITED
    Inventors: Rosanne D. Dunn, Darren R. Jones, Parisa Asvadi, Robert L. Raison, Andrew T. Hutchinson
  • Patent number: 5077391
    Abstract: Immunoglobulin M is purified by absorption upon an insoluble matrix material having chemically bound thereon the protein C1q. The matrix is washed and purified immunoglobulin M is then released from the matrix.
    Type: Grant
    Filed: December 1, 1989
    Date of Patent: December 31, 1991
    Inventors: Robert L. Raison, Simon B. Easterbrook-Smith, Andrew G. Nethery